Compared to Estimates, Nike (NKE) Q4 Earnings: A Look at Key Metrics

Nike reported Q4 revenue of $11.1 billion and EPS of $0.14, both surpassing analyst consensus estimates of $10.72 billion and $0.12, respectively. Despite these beats, revenue declined 12% year-over-year and EPS fell sharply from $1.01, reflecting broad-based weakness across all major geographic segments, with Greater China revenue down 20.8%. This performance contributed to Nike shares underperforming the S&P 500 over the last month.

Analysis

Nike's Q4 results for the period ending May 2025 present a challenging operational picture, where headline beats on revenue and earnings mask significant underlying deterioration. The company reported revenue of $11.1 billion, a 12% year-over-year decline, and an EPS of $0.14, a stark drop from $1.01 in the prior-year quarter. While these figures surpassed consensus estimates by 3.56% and 16.67% respectively, the positive surprise is overshadowed by broad-based weakness across all core segments. Geographically, revenue contracted in North America (-10.9%), EMEA (-8.9%), and most severely in Greater China (-20.8%). The weakness extended to its brands and product lines, with the core Footwear division declining 12.8% and the Converse brand posting a substantial 25.6% year-over-year revenue drop, also missing analyst expectations. This widespread decline indicates a difficult demand environment that is not isolated to one region or product category. The stock's recent underperformance, returning -1.5% against the S&P 500's +5.1% gain over the past month, reflects investor apprehension about these fundamental trends, which seem to outweigh the positive surprise of beating lowered expectations.

Key Decisions for Investors

• Investors should look beyond the headline earnings beat and focus on the severe double-digit year-over-year declines in revenue and profitability, which signal significant fundamental challenges.
• The sharp revenue contractions in Greater China (-20.8%) and the Converse brand (-25.6%) represent material weaknesses that require close monitoring for any signs of stabilization in future quarters.
• Given the stock's recent underperformance relative to the market and the broad-based operational declines, a neutral, market-weight stance seems prudent until there is a clear catalyst for a return to growth.